Quality of Life and Adverse Effects in Epilepsy Patients (EPIKA)
Observational, multicentre, epidemiological study to determine the HRQOL of patients with epilepsy according to treatment sub-group and to validate the Spanish version of the Adverse Events Profile, produced by G. Baker et al. Three treatment groups will be examined: patients receiving only a new anti-epilepsy drug (AED), patients receiving a "classic" AED; patients receiving combination therapy.
|Study Design:||Time Perspective: Prospective|
|Official Title:||Quality of Life and Adverse Effects in Epilepsy Patients According to Treatment Group (EPIKA)|
Please refer to this study by its ClinicalTrials.gov identifier: NCT00302991
|Study Director:||UCB Clinical Trial M. Call Center||+1 877 822 9493 (UCB)|